ST101 Lecture 13: Investigations of OOS/OOT

ST101 Lecture 13: Investigations of OOS/OOT

Session 13: Story Changes and First DCFsПодробнее

Session 13: Story Changes and First DCFs

Out of specification (OOS) and Out of trend (OOT) in pharmaceutical industry l important questionsПодробнее

Out of specification (OOS) and Out of trend (OOT) in pharmaceutical industry l important questions

Investigation of Out of Specification Results | OOS InvestigationПодробнее

Investigation of Out of Specification Results | OOS Investigation

MHRA || OOS Guideline ||Подробнее

MHRA || OOS Guideline ||

Preparing and Investigating Oos/Oot Results In A Regulated EnvironmentПодробнее

Preparing and Investigating Oos/Oot Results In A Regulated Environment

ST101 Lecture 2: Regulations on Stability Program Global Stability RequirementsПодробнее

ST101 Lecture 2: Regulations on Stability Program Global Stability Requirements

ST101 Lecture 9: Stability Program for BiologicsПодробнее

ST101 Lecture 9: Stability Program for Biologics

Difference in OOS investigation between USFDA and MHRA guidlinesПодробнее

Difference in OOS investigation between USFDA and MHRA guidlines

ST101 Lecture 3: QBD Approach for StabilityПодробнее

ST101 Lecture 3: QBD Approach for Stability

2013 Dunster LectureПодробнее

2013 Dunster Lecture

Out Of Specification (OOS) Investigation Phase Ia & Phase Ib (MHRA)Подробнее

Out Of Specification (OOS) Investigation Phase Ia & Phase Ib (MHRA)

OOS I OUT OF SPECIFICATION I HINDIПодробнее

OOS I OUT OF SPECIFICATION I HINDI

5 Root Cause Analysis Tools | RCA ToolsПодробнее

5 Root Cause Analysis Tools | RCA Tools

ST101 Lecture 7: Stability of ParenteralsПодробнее

ST101 Lecture 7: Stability of Parenterals

Актуальное